Pharmaceuticals

Crohn’s Disease Treatment Market 2025–2029: Strategic Opportunities and Growth Insights

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the crohn’s disease treatment market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Crohn’s Disease Treatment Market Now And By 2029?

The crohn’s disease treatment market size has seen significant growth in recent years. It is anticipated to increase from $12.45 billion in 2024 to $13.1 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.2%. This expansion during the historic period can be attributed to several factors, including heightened disease prevalence, advancements in diagnostic techniques, the embrace of biological therapies, increased patient awareness and education, and continuous clinical research and development.

The Crohn’s disease treatment market is projected to experience substantial expansion in the coming years, reaching “$17.34 billion by 2029 with a compound annual growth rate (CAGR) of 7.3%. This anticipated growth over the forecast period is driven by factors such as personalized medicine approaches, the expansion of the biologics market, evolving treatment guidelines, increased healthcare spending, and collaborative research efforts. Key trends identified for the forecast period include the adoption of telemedicine for patient management, continued research into immune modulation strategies, the implementation of patient-centric care models, and the integration of digital health solutions.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp

Which Long-Term Drivers Are Expected To Sustain The Crohn’s Disease Treatment Market?

The increasing occurrence of inflammatory bowel disorders is anticipated to drive the future growth of the Crohn’s disease treatment market. These disorders are defined as a collection of chronic conditions marked by inflammation in the gastrointestinal tract. Such conditions can lead to inflammation and damage anywhere within the digestive system, from the mouth to the anus. The management of Crohn’s disease aims to diminish intestinal inflammation, prevent symptom flare-ups, and sustain remission. For example, in September 2023, information from the National Center for Biotechnology Information, a US-based government organization, showed a similar increase in the prevalence of Crohn’s disease and ulcerative colitis. Inflammatory bowel disease was projected at 825 cases per 100,000 people in 2023, with 410 for Crohn’s disease and 414 for ulcerative colitis and IBD-u. Therefore, the escalating prevalence of these disorders is fueling the expansion of the Crohn’s disease treatment market.

How Is The Crohn’s Disease Treatment Market Classified By Different Segments?

The crohn’s disease treatment market covered in this report is segmented –

1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications

Subsegments:

1) By Antibiotics: Metronidazole, Ciprofloxacin, Other Antibiotics

2) By Amino Salicylates: Mesalamine, Sulfasalazine, Other Amino Salicylates

3) By Corticosteroids: Prednisone, Budesonide, Other Corticosteroids

4) By Immunomodulators: Azathioprine, Methotrexate, Mercaptopurine

5) By Other Drug Types: Biologics, Small Molecules, Other Treatments

What Current And Upcoming Trends Are Shaping The Crohn’s Disease Treatment Market?

Leading companies operating in the crohn’s disease treatment market are developing and securing approval for novel medications, such as biosimilar ustekinumab, with the goal of offering patients more effective and accessible treatment options, ultimately enhancing patient outcomes and their quality of life. Biosimilar ustekinumab is defined as a biologic drug that closely resembles the original ustekinumab, which is a monoclonal antibody used for managing autoimmune conditions. For instance, in July 2024, Sandoz International GmbH, a pharmaceutical company located in Switzerland, introduced Pyzchiva (ustekinumab) across Europe. This launch positioned it as the first ustekinumab biosimilar available in all strengths, including a 130 mg vial specifically for Crohn’s disease. This product is indicated for adults and children over six years old who have plaque psoriasis, psoriatic arthritis, and Crohn’s disease, thereby boosting Sandoz’s immunology portfolio while aiming to improve access to affordable treatments for chronic inflammatory disease.

Who Are The Primary Market Leaders In The Crohn’s Disease Treatment Market?

Major companies operating in the crohn’s disease treatment market include AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Bristol-Myers Squibb Company, Galapagos NV, Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Arena Pharmaceuticals Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Crohn’s Disease Treatment Market?

North America was the largest region in the global Crohn’s disease treatment market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the Crohn’s disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10852&type=smp

Browse Through More Reports Similar to the Global Crohn’s Disease Treatment Market 2025, By The Business Research Company

Alzheimer Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Enteric Disease Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795